/>

Saturday, October 6, 2018

NEWS 06 OCT 2018

NEWS FROM USA

NDA Approvals        

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

05 Oct 2018

Inotersen Injection

Ionis Pharms 

Tegsedi

Label

05 Oct 2018

Elapegademase-Lvlr Injection

Leadiant Biosci 

Revcovi

Label

 

 

ANDA Approvals

           

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

01 Oct 2018

Nitric Oxide Inhalation

Praxair Distribution

Inomax (Mallinckrodt Hosp)

None

03 Oct 2018

Exemestane Tablets

Zydus

Aromasin (Pharmacia And Upjohn)

Five

03 Oct 2018

Entacapone Tablets

Sunshine 

Comtan (Orion Pharma)

Five

03 Oct 2018

Methylphenidate Hydrochloride Solution

Wes Pharma 

Methylin (Specgx LLC)

Four

03 Oct 2018

Prazosin Hydrochloride Capsule

Novitium Pharma

Minipress (Pfizer)

Three

05 Oct 2018

Roflumilast Tablets

Breckenridge 

Daliresp (AstraZeneca )

One (Torrent)

*For more details on ANDA approvals click on the Drug Product Name           

*Highlighted product indicates First generics approval for corresponding RLD

 

Tentative ANDA Approvals           

Approval Date

Drug

Company

28 Sep 2018

Minocycline Hydrochloride

Aurobindo 

03 Oct 2018

Roflumilast

Micro Labs

03 Oct 2018

Ropivacaine Hydrochloride

Gland Pharma 

 

NEW GENERICS LAUNCHES IN US

 

DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Potassium Chloride Oral Solution 

Lupin

Potassium Chloride (Genus Lifesciences)

$ 184.95 Mn

Link

Candesartan Hydrochlorothiazide Tablets (Authorized Generics)

Ani Pharma

HCT (Atacand)

$20 Mn

Link

                  

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

 

No comments:

Post a Comment